Browse Pet Safety Reports
16,698 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 16,698 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 16,698 FDA veterinary adverse event reports for Human.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Apr 5, 2022 | Human | Unknown | Spinosad; Milbemycin Oxime | Stomach upset | Outcome Unknown |
| Apr 5, 2022 | Human | Unknown | Pyrantel Pamoate;Sarolaner | Localised numbness (see also application site SOC) | Outcome Unknown |
| Apr 5, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Leaking; Accidental exposure; Tubes,... | Recovered/Normal |
| Apr 4, 2022 | Human | Unknown | Lotilaner | Headache; Nausea; Diarrhoea | Outcome Unknown |
| Apr 4, 2022 | Human | Unknown | Maropitant Citrate | Joint oedema; Joint pain; Injection site erythema; Joint stiffness; Puncture ... | Outcome Unknown |
| Apr 1, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Recovered/Normal |
| Mar 31, 2022 | Human | Unknown | Tilmicosin | Malaise; Sleepiness - systemic disorder; Congestion of mucous membrane; Eye p... | Outcome Unknown |
| Mar 30, 2022 | Human | Unknown | Pergolide Mesylate | Vomiting | Recovered/Normal |
| Mar 30, 2022 | Human | Unknown | Selamectin;Sarolaner | Abdominal cramp; Diarrhoea; Anorexia; Headache; Flatulence; Numbness; Tinglin... | Recovered/Normal |
| Mar 29, 2022 | Human | Unknown | Praziquantel; Febantel; Pyrantel Pamoate | Stomach upset | Outcome Unknown |
| Mar 28, 2022 | Human | Unknown | Cyclosporine | Burning sensation of the throat; Burning sensation of eye; Nasal irritation | Recovered/Normal |
| Mar 26, 2022 | Human | Unknown | Pimobendan | Hives (see also 'Skin'); Vertigo; Malaise | Outcome Unknown |
| Mar 23, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Throat irritation; Defect Unknown/Not Specified; Accidental exposure; Caps, A... | Ongoing |
| Mar 23, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Medication error; Application site stickiness | Recovered/Normal |
| Mar 22, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Containers, Leaking; Tubes, Leaking; Accidental ... | Recovered/Normal |
| Mar 22, 2022 | Human | Unknown | Oclacitinib Maleate | No sign; Accidental exposure | Recovered/Normal |
| Mar 22, 2022 | Human | Unknown | Fluralaner/Moxidectin Spot-On | Application site stickiness | Recovered/Normal |
| Mar 20, 2022 | Human | Unknown | Eprinomectin | Diarrhoea | Outcome Unknown |
| Mar 19, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Nausea; Application site stickiness | Recovered/Normal |
| Mar 19, 2022 | Human | Unknown | Fluralaner 5.46% 1-Month Chew | Hives (see also 'Skin'); Itching; Throat irritation; Local swelling (not appl... | Recovered/Normal |
| Mar 17, 2022 | Human | Unknown | Meloxicam | Burning sensation of eye; Accidental exposure; Sore eye | Outcome Unknown |
| Mar 16, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Accidental exposure | Recovered/Normal |
| Mar 10, 2022 | Human | Unknown | Oclacitinib Maleate | Vomiting; Accidental exposure | Outcome Unknown |
| Mar 9, 2022 | Human | Unknown | Fenbendazol Granules | Bad taste; Medication error; Incorrect storage of drug; Accidental exposure | Ongoing |
| Mar 8, 2022 | Human | Unknown | Florfenicol; Mometasone Furoate; Terb... | Eye irritation; Eye redness | Ongoing |
| Mar 4, 2022 | Human | Unknown | Moxidectin | Injection site bruising; Puncture wound; Injection site pain; Accidental expo... | Outcome Unknown |
| Mar 4, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Headache; Bad taste; Medication error; Wrong technique in drug usage process;... | Outcome Unknown |
| Mar 2, 2022 | Human | Unknown | Milbemycin/Lufenuron Tablets | Hives (see also 'Skin'); Generalised rash | Ongoing |
| Mar 2, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness | Outcome Unknown |
| Mar 1, 2022 | Human | Unknown | Ophiopogon Japonicus Root Extract | Asthma | Recovered/Normal |
| Mar 1, 2022 | Human | Unknown | Dinoprost Tromethamine | Puncture wound; Accidental exposure | Recovered/Normal |
| Mar 1, 2022 | Human | Unknown | Imidacloprid; Moxidectin | Burning sensation (skin) | Recovered/Normal |
| Feb 28, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Accidental exposure | Recovered/Normal |
| Feb 24, 2022 | Human | Unknown | Bupivacaine | Numbness | Outcome Unknown |
| Feb 24, 2022 | Human | Unknown | Oclacitinib Maleate | Light headedness; Disorder of gastrointestinal flora; Accidental exposure; Di... | Recovered/Normal |
| Feb 23, 2022 | Human | Unknown | Chlorhexidine Digluconate | Dyspnoea; Chest tightness | Ongoing |
| Feb 23, 2022 | Human | Unknown | Spinosad; Milbemycin Oxime | Taste disorder; Accidental exposure | Recovered/Normal |
| Feb 22, 2022 | Human | Unknown | Selamectin;Sarolaner | Respiratory distress; Eye irritation | Recovered/Normal |
| Feb 21, 2022 | Human | Unknown | Cefovecin | Injection site pain; Accidental exposure | Outcome Unknown |
| Feb 21, 2022 | Human | Unknown | Neomycin Sulfate; Thiabendazole; Dexa... | Eye irritation; Accidental exposure | Recovered/Normal |
| Feb 19, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Application site stickiness; Medication error; Wrong technique in drug usage ... | Recovered/Normal |
| Feb 18, 2022 | Human | Unknown | Fluralaner Spot-On Solution | Tracheal and laryngeal disorder NOS; Throat tightness; Localised numbness (se... | Recovered/Normal |
| Feb 17, 2022 | Human | Unknown | Estriol Tablets | Burning sensation (skin); Shaking | Ongoing |
| Feb 17, 2022 | Human | Unknown | Florfenicol; Mometasone Furoate; Terb... | Eye irritation | Recovered/Normal |
| Feb 16, 2022 | Human | Unknown | Florfenicol Inj Sol 30% W Pg | Injection site pain; Injection site reaction NOS; Accidental exposure | Outcome Unknown |
| Feb 14, 2022 | Human | Unknown | Selamectin;Sarolaner | Burning sensation (skin); Accidental exposure | Outcome Unknown |
| Feb 11, 2022 | Human | Unknown | Oclacitinib Maleate | Headache; Accidental exposure | Ongoing |
| Feb 11, 2022 | Human | Unknown | Oclacitinib Maleate | Bad taste; Accidental exposure | Ongoing |
| Feb 10, 2022 | Human | Unknown | Tilmicosin | Injection site bleeding | Recovered/Normal |
| Feb 10, 2022 | Human | Unknown | Enrofloxacin; Silver Sulfadiazine | Vision blurred; Accidental exposure | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.